ORIC
ORIC Pharmaceuticals, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding):
keluasan pemegang +11.1% ·
aliran saham +26.5% ·
posisi baru bersih +10.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | 0 | 59.02M | $639.12M | +7 | −7 |
| Q1 2026 | 75 | +3 | 50.35M | $637.44M | +9 | −6 |
| Q4 2025 | 72 | +1 | 55.15M | $451.14M | +1 | — |
| Q3 2025 | 17 | 0 | 34.78M | $417.41M | — | — |
| Q2 2025 | 14 | +1 | 27.12M | $275.30M | +3 | −2 |
| Q1 2025 | 10 | +1 | 12.33M | $68.78M | +2 | −1 |
| Q4 2024 | 9 | -1 | 9.74M | $78.61M | — | −1 |
| Q3 2024 | 9 | 0 | 7.63M | $78.26M | +1 | −1 |
| Q2 2024 | 9 | — | 8.42M | $59.53M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 6.57M | +48.3% | $36.68M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasif) | 2.20M | +19.0% | $12.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 1.33M | +2.9% | $7.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 1.33M | +2.9% | $7.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 1.31M | +2.1% | $7.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasif) | 1.31M | +2.1% | $7.29M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 511.89K | +1305.3% | $2.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 178.22K | -4.4% | $994,451 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 178.22K | -4.4% | $994,451 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 76.99K | -44.9% | $429,604 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 53.98K | +95.3% | $301,225 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 49.53K | Baru | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 49.53K | Baru | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 49.53K | Baru | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 49.53K | Baru | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 49.53K | Baru | $276,376 | 0.0% | New | 1 | SEC ↗ |
| 17 | Marshall Wace ✦ | 47.70K | Baru | $266,138 | 0.0% | New | 1 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| AQR Capital Management | $276,376 | 0.0% |
| Marshall Wace | $266,138 | 0.0% |
Telah keluar
| Adage Capital Partners | $4.04M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 181 pemegang, 119.04M saham, $1.43B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.